tradingkey.logo

Bioventus Inc

BVS
8.510USD
+0.300+3.65%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
569.95MValor de mercado
54.31P/L TTM

Mais detalhes de Bioventus Inc Empresa

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Informações de Bioventus Inc

Código da empresaBVS
Nome da EmpresaBioventus Inc
Data de listagemFeb 11, 2021
CEOClaypoole (Robert E)
Número de funcionários930
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 11
Endereço4721 Emperor Boulevard, Suite 100
CidadeDURHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27703
Telefone19194746700
Sitehttps://www.bioventus.com/
Código da empresaBVS
Data de listagemFeb 11, 2021
CEOClaypoole (Robert E)

Executivos da empresa Bioventus Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+26493.00%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+26493.00%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+34068.00%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+26493.00%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Robert E. Claypoole
Mr. Robert E. Claypoole
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Director
Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+26493.00%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+26493.00%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+34068.00%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+26493.00%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Pain Treatments
67.18M
48.45%
Surgical solutions
50.17M
36.18%
Restorative Therapies
21.31M
15.37%
Por RegiãoUSD
Nome
Receita
Proporção
United States
123.31M
88.94%
International
15.34M
11.06%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pain Treatments
67.18M
48.45%
Surgical solutions
50.17M
36.18%
Restorative Therapies
21.31M
15.37%

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.39%
Outro
47.83%
Investidores
Investidores
Proporção
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.39%
Outro
47.83%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
22.99%
Venture Capital
19.55%
Investment Advisor
15.76%
Hedge Fund
14.00%
Corporation
9.30%
Individual Investor
2.58%
Research Firm
1.72%
Insurance Company
0.47%
Bank and Trust
0.22%
Outro
13.42%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
319
49.87M
91.76%
-1.55K
2025Q3
324
49.87M
92.42%
+451.64K
2025Q2
315
49.43M
88.24%
+1.39M
2025Q1
300
47.59M
85.68%
-9.15M
2024Q4
302
46.29M
87.45%
+580.76K
2024Q3
303
45.64M
84.02%
-1.26M
2024Q2
271
47.35M
78.83%
+4.38M
2024Q1
269
42.96M
79.86%
-7.88M
2023Q4
267
41.98M
81.20%
+236.50K
2023Q3
256
41.69M
80.71%
+844.38K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
EW Healthcare Partners
13.02M
19.44%
--
--
Sep 30, 2025
Juniper Investment Company, LLC
6.94M
10.36%
--
--
Sep 30, 2025
Smith & Nephew Group plc
6.23M
9.3%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
5.81M
8.68%
+529.82K
+10.03%
Sep 30, 2025
The Vanguard Group, Inc.
2.88M
4.3%
+108.48K
+3.92%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.81M
4.2%
-6.12K
-0.22%
Sep 30, 2025
Royce Investment Partners
1.26M
1.89%
+170.90K
+15.65%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.10M
1.64%
+45.95K
+4.36%
Sep 30, 2025
American Century Investment Management, Inc.
1.09M
1.63%
-32.95K
-2.93%
Sep 30, 2025
Kent Lake PR LLC
1.00M
1.49%
+650.16K
+185.74%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Vanguard US Multifactor ETF
0.1%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.09%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Vanguard US Value Factor ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
Ver Mais
Vanguard US Multifactor ETF
Proporção0.1%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.1%
Harbor Human Capital Factor US Small Cap ETF
Proporção0.09%
Fidelity Enhanced Small Cap ETF
Proporção0.09%
iShares Micro-Cap ETF
Proporção0.06%
Principal U.S. Small-Cap ETF
Proporção0.05%
Vanguard US Value Factor ETF
Proporção0.04%
Humankind US Stock ETF
Proporção0.03%
WisdomTree US SmallCap Fund
Proporção0.03%
Avantis US Small Cap Value ETF
Proporção0.03%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI